Exelixis (NASDAQ: EXEL) reported Q2 EPS of ($0.22), $0.01 worse than the analyst estimate of ($0.21). Revenue for the quarter came in at $7.99 million versus the consensus estimate of $8.69 million.

For earnings history and earnings-related data on Exelixis (EXEL) click here.